Zydus Cadila to apply for Phase-3 trials in December, hopes to launch vaccine by March

The Ahmedabad-based drug maker will submit the results of its phase-2 trials next week, which "will ascertain the safety, dose and efficacy of the potential vaccine", said the person who requested not to be identified.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2HGL2yX
via IFTTT